Pfizer
PFE
PFE
3,032 hedge funds and large institutions have $145B invested in Pfizer in 2023 Q2 according to their latest regulatory filings, with 144 funds opening new positions, 1,372 increasing their positions, 1,253 reducing their positions, and 180 closing their positions.
New
Increased
Maintained
Reduced
Closed
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
less ownership
Funds ownership: →
less funds holding
Funds holding: →
less capital invested
Capital invested by funds: $ → $
20% less first-time investments, than exits
New positions opened: 144 | Existing positions closed: 180
27% less call options, than puts
Call options by funds: $1.71B | Put options by funds: $2.36B
36% less funds holding in top 10
Funds holding in top 10: 80 → 51 (-29)
Holders
3,032
Holding in Top 10
51
Calls
$1.71B
Puts
$2.36B
Top Buyers
| 1 | +$552M | |
| 2 | +$349M | |
| 3 | +$282M | |
| 4 |
National Bank of Canada
Montreal,
Quebec, Canada
|
+$260M |
| 5 |
Barclays
London,
United Kingdom
|
+$252M |
Top Sellers
| 1 | -$1.26B | |
| 2 | -$1.06B | |
| 3 | -$202M | |
| 4 |
T. Rowe Price Associates
Baltimore,
Maryland
|
-$171M |
| 5 |
Susquehanna International Group
Bala Cynwyd,
Pennsylvania
|
-$164M |